C. Le Boulaire

Longitudinal follow-up of cellular and humoral immunity induced by recombinant adenovirus-mediated gene therapy in cancer patients.

T. Tursz, J. Guillet, F. Le Gal, 2000, Human gene therapy.

Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products.

P. Opolon, L. Zitvogel, A. Cesne, 1997, The Journal of clinical investigation.

Increased apoptosis, changes in intracellular Ca2+, and functional alterations in lymphocytes and macrophages after in vitro exposure to static magnetic field.

Philippe P Roux, C. Pinsky, M. Fournier, 1998, Journal of toxicology and environmental health. Part A.

Immune Response to Recombinant Adenovirus in Humans: Capsid Components from Viral Input Are Targets for Vector-Specific Cytotoxic T Lymphocytes

T. Tursz, M. Mehtali, P. Boulanger, 2000, Journal of Virology.